|
Biologic Therapeutic for Graft-versus-Host Disease (GvHD)
Application
Biotherapeutic activation of toll-like receptor 5 (TLR5) to treat graft-versus-host disease (GvHD).
Key Benefits
Administration of flagellin reduces both acute and chronic GvHD.
Contrary to immunosuppressive drugs, flagellin enhances immunity and protects patients from opportunistic infections.
Market Summary
Transplant recipients...
Published: 11/6/2023
Contributor(s): Mohammad Hossain, Andrew Gewirtz, John Roback, Edmund Waller
|